Table 2. Patients’ characteristics and correlation of patients’ clinicopathological parameters with TSLP overexpression.

	Total patients (n)	TSLP overexpression		P-value*
		No n (%)	Yes n (%)
Age at diagnosis(y)
<60	89	44 (49.4%)	45 (50.6%)	0.009*
≥60	55	15 (27.3%)	40 (72.7%)
Histological type
Serous	89	33 (37.1%)	56 (62.9%)	0.022*
Mucinous	7	5 (71.4%)	2 (28.6%)
Endometriosis	13	6 (46.2%)	7 (53.8%)
Clear cell	10	5 (50%)	5 (50%)
Mixed	10	8 (80%)	2 (20%)
Transitional cell	7	1 (14.3%)	6 (85.7%)
Undifferentiated	8	1 (12.5%)	7 (87.5%)
FIGO stage
I and II	81	46 (56.1%)	35 (43.9%)	<0.001*
III and IV	63	13 (22.2%)	50 (77.8%)
Histological differentiation
G1	34	20 (58.8%)	14 (41.2%)	0.015*
G2	110	39 (35.5%)	71 (64.5%)
Pelvic involvement
No	77	46 (59.7%)	31 (40.3%)	<0.001*
Yes	67	13 (19.4%)	54 (80.6%)
Lymph node involvement
No	110	52 (47.3%)	58 (52.7%)	0.034*
Yes	25	6 (24%)	19 (76%)
No data	9
Presence of ascites
No	93	41 (44.1%)	52 (55.9%)	0.305
Yes	51	18 (35.3%)	33 (64.7%)
Menopause
No	53	29 (54.7%)	24 (45.2%)	0.080
Yes	90	29 (32.3%)	61 (67.7%)
No data	1
CA199
Negative	78	23 (29.5)	55 (71.5)	0.064
Positive	24	12 (50%)	12 (50%)
No data	42
CA125
Negative	13	5 (38.5%)	8 (61.5%)	0.856
Positive	92	33 (35.9%)	59 (64.1%)
No data	39
CA153
Negative	42	18 (42.9%)	24 (57.1%)	0.123
Positive	54	15 (27.8%)	39 (72.2%)
No data	48
SF
Negative	68	28 (41.2%)	40 (58.8%)	0.089
Positive	30	7 (23.3%)	23 (76.7%)
No data	46

G1: low-grade serous, low-grade mucinous, both grades I and II endometrioid, mixed and transitional cell EOCs;

G2: high-grade serous, high-grade mucinous, clear cell, undifferentiated EOCs and grade III endometrioid, mixed and transitional cell EOCs.

P values were calculated by Chi-square test.

^*P<0.05 was considered significant.